(Q37439565)

20 August 2017

1 reference

title

The role of stem cell transplantation in the management of chronic lymphocytic leukaemia (English)

1 reference

stem cell transplantation

20 August 2017

0 references

1 reference

1 reference

Issa Khouri

1 reference

20 August 2017

Constantine S Tam

1 reference

20 August 2017

publication date

1 June 2009

1 reference

20 August 2017

published in

Hematological Oncology

1 reference

20 August 2017

1 reference

20 August 2017

1 reference

20 August 2017

page(s)

53-60

1 reference

Incidence of chronic lymphocytic leukemia in Olmsted County, Minnesota, 1935 through 1989, with emphasis on changes in initial stage at diagnosis

20 August 2017

cites work

1 reference

HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry.

21 January 2018

1 reference

Genomic aberrations and survival in chronic lymphocytic leukemia

21 January 2018

1 reference

7 January 2021

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

1 reference

7 January 2021

ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia

1 reference

7 January 2021

Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemia

1 reference

7 January 2021

The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathy

1 reference

7 January 2021

High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial

1 reference

7 January 2021

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

1 reference

7 January 2021

Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results

1 reference

7 January 2021

Bone marrow transplantation in chronic lymphocytic leukemia and lymphomas

1 reference

7 January 2021

Stem cell transplantation for chronic lymphocytic leukaemia

1 reference

7 January 2021

Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia

1 reference

7 January 2021

Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responses

1 reference

7 January 2021

Stem cell transplantation for chronic lymphocytic leukemia: different outcome after autologous and allogeneic transplantation and correlation with minimal residual disease status.

1 reference

7 January 2021

Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia

1 reference

7 January 2021

The prognostic impact of autologous stem cell transplantation in patients with chronic lymphocytic leukemia: a risk-matched analysis based on the VH gene mutational status

1 reference

7 January 2021

Allogeneic Stem-Cell Transplantation May Overcome the Adverse Prognosis of UnmutatedVHGene in Patients With Chronic Lymphocytic Leukemia

1 reference

7 January 2021

Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia

1 reference

7 January 2021

Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival

1 reference

7 January 2021

Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation

1 reference

7 January 2021

1 reference

7 January 2021

Long-term follow-up of patients with CLL treated with allogeneic hematopoietic transplantation

1 reference

7 January 2021

Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion.

1 reference

7 January 2021

Genetically identical twin transplantation for chronic lymphocytic leukemia

1 reference

7 January 2021

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

7 January 2021

Rituximab for steroid-refractory chronic graft-versus-host disease

1 reference

7 January 2021

Treatment of refractory chronic GVHD with rituximab: a GITMO study.

1 reference

7 January 2021

Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocytic leukaemia

1 reference

7 January 2021

1 reference

7 January 2021

Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.

1 reference

7 January 2021

Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia

1 reference

7 January 2021

Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia

1 reference

7 January 2021

Allogeneic Transplant with Reduced Intensity Conditioning Regimens may Overcome the Poor Prognosis of B-Cell Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Variable Heavy-Chain Gene and Chromosomal Abnormalities (11q- and 17p-)

1 reference

7 January 2021

Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCR.

1 reference

7 January 2021

Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis

1 reference

7 January 2021

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

1 reference

7 January 2021

The role of alemtuzumab in nonmyeloablative hematopoietic transplantation

1 reference

7 January 2021

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders

1 reference

7 January 2021

Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study

1 reference

7 January 2021

Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial

1 reference

7 January 2021

Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus.

1 reference

7 January 2021

Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis

1 reference

7 January 2021

Richter syndrome: biology, incidence, and therapeutic strategies

1 reference

7 January 2021

Identifiers

DOI

10.1002/HON.884

1 reference

20 August 2017

1 reference